Navigation Links
Aware, Inc. Reports Second Quarter 2009 Financial Results
Date:8/1/2009

BEDFORD, Mass., July 30 /PRNewswire-FirstCall/ -- Aware, Inc. (Nasdaq: AWRE), a leading supplier of broadband technology and biometrics software, today reported financial results for its second quarter ended June 30, 2009.

Revenues for the second quarter of 2009 were $5.8 million, a decrease of 7% compared to $6.2 million in the same quarter last year. For the six months ended June 30, 2009, revenues decreased 14% to $10.3 million, compared to $12.0 million in the same period a year ago.

The Company reports its net income and basic and diluted net income per share in accordance with U.S. generally accepted accounting principles (GAAP), and additionally, on a non-GAAP basis. Non-GAAP net income, where applicable, excludes the effect of stock-based compensation expense. The company uses the non-GAAP information internally to evaluate its operating performance and believes these non-GAAP measures are useful to investors as they provide additional insight into the underlying operating results. However, non-GAAP measures are not stated in accordance with, should not be considered in isolation from, and are not a substitute for, GAAP measures. A reconciliation of GAAP to non-GAAP results has been provided in the attached financial tables.

The GAAP net loss for the second quarter of 2009 was $1.6 million, or $0.08 per diluted share, which included $0.4 million of stock-based compensation charges in accordance with the provisions of FAS 123(R). This compared to a GAAP net loss of $1.3 million, or $0.05 per diluted share, for the same period a year ago. GAAP net loss for the six months ended June 30, 2009 was $3.7 million, or $0.17 per share, compared to a net loss of $2.5 million, or $0.11 per share, for the same period a year ago.

The non-GAAP net loss for the second quarter
'/>"/>

SOURCE Aware, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology news :

1. Aware, Inc. Announces Q209 Earnings Conference Call
2. Aware, Inc. Reports First Quarter 2009 Financial Results
3. Aware, Inc. Reports First Quarter 2009 Financial Results
4. Aware, Inc. Announces Final Results of Dutch Auction Tender Offer
5. Aware, Inc. Announces Q1 09 Earnings Conference Call
6. Aware, Inc. Amends and Extends Dutch Auction Tender Offer
7. Aware, Inc. Announces Preliminary Results of Dutch Auction Tender Offer
8. Aware, Inc. Amends and Extends Dutch Auction Tender Offer
9. Aware, Inc. Commences Dutch Auction Tender Offer
10. Aware, Inc. Commences Dutch Auction Tender Offer
11. Aware, Inc. Reports Fourth Quarter and 2008 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...search presents strong evidence that the "synergis... traffic-related pollution and indoor endotoxin ca... other exposure alone. , Environmental health ...llege of Medicine have shown that children exposed...and indoor endotoxin during early life are six tim...
(Date:11/23/2009)...ass. November 23, 2009 Applied mathematicians di...a lancifolia ), a characteristic long leaf with a ...les along the edges. The simple cause of the lily,...bending during differential growthwas revealed by ... ribbons. , Haiyi Liang, a postdoctoral student ...
(Date:11/23/2009)... the Wildlife Conservation Society says that weste... Republic of Congopart of the "mother lode" of mor...coming increasingly threatened by growing humans a...otection of the swamp forests adjacent to the sout...ent surveys confirmed that high densities of the g...
Breaking Biology News(10 mins):Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2The cause behind the characteristic shape of a long leaf revealed 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Employee Wellness Programs Demonstrate Positive Return on Investment for Businesses 52498 1Employee Wellness Programs Demonstrate Positive Return on Investment for Businesses 52498 2Employee Wellness Programs Demonstrate Positive Return on Investment for Businesses 52498 3St John 26apos 3Bs Hospital Acquires Latest Technology in Robotic Assisted Surgery 52495 1St John 26apos 3Bs Hospital Acquires Latest Technology in Robotic Assisted Surgery 52495 2St John 26apos 3Bs Hospital Acquires Latest Technology in Robotic Assisted Surgery 52495 3eMindful com Launches Live Interactive Online Yoga Classes 52492 1eMindful com Launches Live Interactive Online Yoga Classes 52492 2eMindful com Launches Live Interactive Online Yoga Classes 52492 3
...rs from Case Western Reserve University and Yale U...nderstanding the cause behind why some pregnant wo...thout any signs of an infection. , Using gene-clo...ximately 60 percent of the bacteria present in wom...y traditional culture testing considered the gold...
...uke University Medical Center have identified a va...tibility to early coronary artery disease. For yea...rly-onset form of the disease was inherited, but t...l now. The results are published January 2 in the ...ous study, a region on chromosome 7 was linked to ...
...sity researchers Hao Yan and Yan Liu imagine and a...athomably small. Their medium is the double-helica...ring near limitless construction potential. , In...iu, researchers at ASU,s Biodesign Institute and f...stry, reveal for the first time the three-dimensio...
Other Biology News:Uncultured bacteria found in amniotic fluids of women who experience preterm births 2Genetic variation may lead to early cardiovascular disease 2The gold standard: Biodesign Institute researchers use nanoparticles to make 3-D DNA nanotubes 2The gold standard: Biodesign Institute researchers use nanoparticles to make 3-D DNA nanotubes 3
(Date:11/24/2009)...Call/--IES(Nasdaq: IESC ),aleadingnationalprovider...thecommercial,industrialandresidentialmarkets,anno...rdedacontractfromManhattanTorconJVtoinstalltheelec...cementfacilityattheU.S.ArmyMedicalResearchInstitut...erick,Md. ,, ThenewUSAMRIIDreplacementfacilityw...
(Date:11/24/2009)...investment bank KTA Capital,s client Neuren Pharma...onvertible note private placement with a U.S. inst...nged by KTA Capital as Neuren,s exclusive placemen...w York (PRWEB) November 23, 2009 -- The independen...;KTA Capital") has announced that its client ...
(Date:11/24/2009)...24/PRNewswire-FirstCall/--DowAgroSciencesCanadaann...visionofThompsonsLimitedofBlenheim,Ontario.Theaddi...currentseedsbusinessasthecompanyanticipatestheintr...cesHerbicideTolerantTraitTechnologyincornin2012.Th..., "Thisacquisitionbringstogethertwostrongprogressi...
(Date:11/24/2009)...tCall/--Sigma-AldrichCorporation(Nasdaq: SIAL )wil...ember1stat1:45PMGMTinLondon,7:45AMUS/CST.Intereste...netavailableat http://inve s tor.sig m a a ...sthisfile. ,, AboutSigma-Aldrich: Sigma-Aldr...tschemicalandbiochemicalproductsandkitsareusedinsc...
Breaking Biology Technology:Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3
...NTA MONICA, Calif., March 19 Kalologie Skincare t...ice President of La Jolla,Pharmaceutical Company, ...tors. Mr. Caviar previously served as Vice Preside...th solid operational skills," said William,Brennan...from Niv,s unique,insight in the growing aesthetic...
...INACH, Switzerland, March 19 Arpida Ltd.,(SWX: AR...g Application,(NDA) in an electronic format for in...d Skin and Skin Structure Infections (cSSSI) to th...s requested a Priority designation for,the review ...ine which,exhibits a rapidly bactericidal action a...
...LTHAM, Mass., March 18 Inverness Medical,Innovati...d marketer of rapid,diagnostic products for the co...hat it will attend the upcoming Bank of America 20...March 26-27, 2008 at the Four Seasons,Hotel in Bos...on Russell,Vice President, Finance, will attend. T...
Other Biology Technology:Ex-Allergan Vice President Joins Kalologie Skincare Board of Directors 2Arpida Submits New Drug Application for Intravenous Iclaprim for Treatment of Skin Infections 2Arpida Submits New Drug Application for Intravenous Iclaprim for Treatment of Skin Infections 3Inverness Medical Innovations to Participate at Bank of America 2008 Smid Cap Conference on March 26, 2008 2
NuPAGE Antioxidant from Invitrogen
CCF4-AM from Invitrogen
Chlorine-36 from GE Healthcare, formerly Amersham Biosciences
Src cDNA Expression Kit (wild type) from Upstate
Biology Products: